Bright Green Corporation
| NASDAQ: BGXX | Healthcare / Drug Manufacturers / USA |
| 0.3674 | -0.0191 | -4.94% | Vol 215.55K | 1Y Perf -61.19% |
| Oct 4th, 2023 16:00 DELAYED |
| BID | 0.3659 | ASK | 0.3974 | ||
| Open | 0.3749 | Previous Close | 0.3865 | ||
| Pre-Market | - | After-Market | 0.40 | ||
| - - | 0.03 7.78% |
| Target Price | - | Analyst Rating | — — 0.00 | |
| Potential % | - | Finscreener Ranking | — - | |
| Insiders Trans % 3/6/12 mo. | -/-/- | Value Ranking | — - | |
| Insiders Value % 3/6/12 mo. | -/-/- | Growth Ranking | — - | |
| Insiders Shares Cnt. % 3/6/12 mo. | -/-/- | Income Ranking | — - | |
| Price Range Ratio 52W % | 2.21 | Earnings Rating | — | |
| Market Cap | 65.99M | Earnings Date | 13th Nov 2023 | |
| Alpha | -0.10 | Standard Deviation | 0.33 | |
| Beta | 0.65 |
Today's Price Range 0.36490.3845 | 52W Range 0.33331.88 |
Summary:
Sell
| Technical Indicators: | Neutral |
| Moving Averages: | Strong Sell |
| Performance | |||
|---|---|---|---|
| 1 Week | -5.31% | ||
| 1 Month | -22.49% | ||
| 3 Months | -62.05% | ||
| 6 Months | -65.01% | ||
| 1 Year | -61.19% | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - |
| Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
ROE (5Y Avg) | - | |||
ROE last 12 Months | -202.39 | |||
ROA (5Y Avg) | - | |||
ROA last 12 Months | -147.81 | |||
ROC (5Y Avg) | - | |||
ROC last 12 Months | -175.27 | |||
Return on invested Capital Q | -49.96 | |||
Return on invested Capital Y | -11.21 | |||
Assets Turnover | 0.00 | |||
Receivables Turnover | - |
| Valuation | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| -2.70 | ||||
| 5.93 | ||||
| - | ||||
| - | ||||
| -7.80 | ||||
| -0.03 | ||||
| 5.93 | ||||
| 0.08 | ||||
| 75.87M | ||||
| Forward PE | - | |||
| PEG | - |
| Financial Strength | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 1.40 | ||||
| 1.50 | ||||
| 0.13 | ||||
| 0.15 | ||||
| - | ||||
| Leverage Ratio | 1.40 |
| Profitability | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| - |
| Revenue | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| 0.00 | ||||
| 0.00 | ||||
| - | ||||
| - |
| Dividends | Value | Industry | S&P 500 | US Markets |
|---|---|---|---|---|
| - | ||||
| - | ||||
| - | ||||
| - | ||||
| Payout ratio | - |
| Earnings History | Estimate | Reported | Surprise % |
|---|---|---|---|
| Q04 2022 | - | -0.01 | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Earnings Per End | Estimate | Revision % | Trend |
|---|---|---|---|
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| - | - | - | - |
| Next Report Date | 13th Nov 2023 |
| Estimated EPS Next Report | - |
| Estimates Count | - |
| EPS Growth Next 5 Years % | - |
| Volume Overview | |
|---|---|
| Volume | 215.55K |
| Shares Outstanding | 179.62K |
| Shares Float | 56.96M |
| Trades Count | 1.10K |
| Dollar Volume | 80.30K |
| Avg. Volume | 575.43K |
| Avg. Weekly Volume | 386.67K |
| Avg. Monthly Volume | 769.17K |
| Avg. Quarterly Volume | 570.45K |
Bright Green Corporation (NASDAQ: BGXX) stock closed at 0.3674 per share at the end of the most recent trading day (a -4.94% change compared to the prior day closing price) with a volume of 215.55K shares and market capitalization of 65.99M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 0 people. Bright Green Corporation CEO is .
The one-year performance of Bright Green Corporation stock is -61.19%, while year-to-date (YTD) performance is -21.75%. BGXX stock has a five-year performance of %. Its 52-week range is between 0.33325 and 1.88, which gives BGXX stock a 52-week price range ratio of 2.21%
Bright Green Corporation currently has a PE ratio of -2.70, a price-to-book (PB) ratio of 5.93, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -147.81%, a ROC of -175.27% and a ROE of -202.39%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.
Of the last four earnings reports from Bright Green Corporation, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Bright Green Corporation’s next earnings report date is 13th Nov 2023.
The consensus rating of Wall Street analysts for Bright Green Corporation is — (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Bright Green Corporation stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Bright Green Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Bright Green Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 5.22, ATR14 : 0.05, CCI20 : -37.94, Chaikin Money Flow : -0.39, MACD : -0.05, Money Flow Index : 35.86, ROC : 1.71, RSI : 40.65, STOCH (14,3) : 52.85, STOCH RSI : 1.00, UO : 43.68, Williams %R : -47.15), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Bright Green Corporation in the last 12-months were: Elmasri Saleem (Buy at a value of $0)
Bright Green Corporation
Bright Green Corp is a provider of cannabis, cannabis-related products, and other legal medicinal plant-based therapies, manufactured for research and pharmaceutical applications, as well as being an active ingredient in consumer-based solutions. The company plans to focus on the development of cannabis strains and sales of products with high contents of CBN (cannabinol) and CBG (cannabigerol).
CEO:
Telephone: +1 201 370-1140
Address: 401 East Las Olas Boulevard, Ft. Lauderdale 33301, FL, US
Number of employees: 0
